Zimmer Biomet
766 hedge funds and large institutions have $21.6B invested in Zimmer Biomet in 2016 Q2 according to their latest regulatory filings, with 78 funds opening new positions, 270 increasing their positions, 245 reducing their positions, and 51 closing their positions.
53% more first-time investments, than exits
New positions opened: 78 | Existing positions closed: 51
18% more funds holding in top 10
Funds holding in top 10: 17 → 20 (+3)
14% more capital invested
Capital invested by funds: $18.9B → $21.6B (+$2.65B)
10% more repeat investments, than reductions
Existing positions increased: 270 | Existing positions reduced: 245
3% more funds holding
Funds holding: 747 → 766 (+19)
0.53% more ownership
Funds ownership: 91.99% → 92.53% (+0.53%)
3% less call options, than puts
Call options by funds: $46.9M | Put options by funds: $48.2M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Winslow Capital Management
Minneapolis,
Minnesota
|
+$300M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$158M |
| 3 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$156M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$152M |
| 5 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$151M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KKRC
Kohlberg Kravis Roberts & Co
New York
|
-$439M |
| 2 |
TGHSA
TPG Group Holdings (SBS) Advisors
Fort Worth,
Texas
|
-$428M |
| 3 |
Goldman Sachs
New York
|
-$398M |
| 4 |
Bessemer Group
Woodbridge,
New Jersey
|
-$80.7M |
| 5 |
SC
Sculptor Capital
New York
|
-$71.7M |
ZBH Hedge Fund Activity: Q2 2016 in Review
766 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Zimmer Biomet (ZBH) for Q2 2016, worth a combined $21.6B — up 14% from $18.9B a quarter earlier.
Buyers outnumbered sellers: 78 funds opened new ZBH positions and 51 closed out — a net gain of 27 holders — while 270 added to existing stakes and 245 trimmed.
The largest buyer was Winslow Capital Management, opening a new position worth an estimated $300M. The largest seller was Kohlberg Kravis Roberts & Co, cutting an estimated $439M.
- 766 institutional investors held Zimmer Biomet (ZBH) as of Q2 2016, up from 747 in Q1 2016.
- Funds reported $21.6B of Zimmer Biomet stock for Q2 2016, up 14% quarter-over-quarter.
- 78 funds opened new Zimmer Biomet positions in Q2 2016 and 51 closed out, a net change of +27 holders.
- The largest Zimmer Biomet buyer in Q2 2016 was Winslow Capital Management, an estimated $300M added.
- The largest Zimmer Biomet seller in Q2 2016 was Kohlberg Kravis Roberts & Co, an estimated $439M sold.
Based on aggregated 13F filings for Q2 2016.